Kura Oncology, Inc.
Kura Oncology, Inc. (KURA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KURA · as of Jun 8, 2026
Key Statistics
Explore Kura Oncology, Inc. Data
kura stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 87.5%
The KURA analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $22.00, representing +151.72% upside from the current price of $8.74.
Competitors & Peers
kura competitorsKURA
BCAX
EYPT
MRVI
PRME
PROKStock Performance
Full HistoryAbout Kura Oncology, Inc.
Kura Oncology, Inc. a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidat…
what is kura oncology, inc. · kura stock overview · kura oncology, inc. company profile · who is kura oncology, inc. ceo · kura NASDAQ · kura oncology, inc. headquarters · kura oncology, inc. business segments
About Stock Overview & Key Data
Kura Oncology, Inc. (KURA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 16, 2015. As of the latest trading session, KURA stock price is $8.74, with a market capitalization of $775.9M. The stock has returned +29.87% over the past 12 months and -15.88% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Kura Oncology, Inc. stock is Buy, with an average 12-month price target of $22.00. In fiscal year 2025, Kura Oncology, Inc. reported revenue of $67.5M and net income of -$278.7M. For detailed data — including Kura Oncology, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kura Oncology, Inc. (KURA) stock price is $8.74. The stock is traded on NASDAQ under the ticker symbol KURA. The 52-week range is $5.45 – $12.49.